Finance

Lists
Why is CRMD down 3.72%?
Dive Deeper
CRMD:NASDAQ
CorMedix Inc
$4.66
-3.72%
(-0.18) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRMD...
Open
$4.88
High
$5.06
Low
$4.65
Mkt. cap
370.36M
Avg. vol.
1.71M
Volume
2.39M
P/E ratio
2.19
52-wk high
$13.02
52-wk low
$4.65
EPS
$2.13
Beta
1.48
Shares outstanding
77.94M
No. of employees
191
Open
$4.88
High
$5.06
Low
$4.65
Mkt. cap
370.36M
Avg. vol.
1.71M
Volume
2.39M
P/E ratio
2.19
52-wk high
$13.02
52-wk low
$4.65
EPS
$2.13
Beta
1.48
Shares outstanding
77.94M
No. of employees
191
News stories
From web sources and news partners
About CorMedix Inc
CEO-
Employees191
Founded2006
HeadquartersBerkeley Heights, New Jersey, United States
SectorHealth Care
IndustryPharmaceutical industry
Analyst ratings
Based on 5 analysts giving stock ratings to CRMD in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CRMD in the last 3 months.
Highest
Current $4.66
$16.00 (+243.35%)
Average
$14.00 (+200.43%)
Lowest
$13.00 (+178.97%)
Analyst
Recommendation
Action
Price target
Projected
Date
Les Sulewski
Oppenheimer
Buy
Reiterated
$13.00
+179%
11/13/2026
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
$13.00
+179%
11/13/2026
Serge Belanger
Needham
Buy
Maintained
$14.00
+200.4%
11/10/2026
Leonid Timashev
RBC Capital
Buy
Reiterated
$14.00
+200.4%
11/12/2026
Roanna Ruiz
Leerink Partners
Buy
Reiterated
$16.00
+243.3%
10/20/2026
Unknown Analyst
Oppenheimer
Buy
Initiated
$15.00
+221.9%
09/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
128.62M
127.43M
101.93M
54.52M
Cost of goods sold
11.17M
12.00M
14.50M
-
Cost of revenue
11.17M
12.00M
14.50M
-
Research and development expenses
8.60M
7.21M
6.68M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29.38M
34.25M
27.53M
-
Operating expense
48.12M
51.76M
44.52M
-
Total operating expenses
59.29M
63.77M
59.02M
-
Operating income
69.33M
63.66M
42.91M
-
Other non operating income
-
-268.00K
-71.00K
-
EBT including unusual items
56.45M
55.64M
38.73M
-
EBT excluding unusual items
68.47M
63.39M
42.84M
-
Income tax expense
42.43M
17.04M
12.74M
-
Effective tax rate
75.16%
30.63%
32.90%
-
Other operating expenses
-
-
-
-
Net income
14.02M
38.60M
25.99M
-
Net profit margin
10.90%
30.29%
25.50%
-27.00%
Earnings per share
0.16
0.35
-
-
Interest and investment income
889.98K
-
-
-
Interest expense
-1.82M
-
-
-
Net interest expenses
-927.10K
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
79.76M
74.20M
53.45M
-
Gain or loss from assets sale
-86.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps